[NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis]

J Qin1

  • 1Shanghai No. 2 TB and Lung Tumour Hospital.

Insights

Natural killer (NK) cell activity was higher in pulmonary tuberculosis patients compared to healthy individuals. T lymphocyte subset counts were lower in patients, but their ratio remained unchanged, with NK cell activity correlating with lesion progression.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Context:

  • Pulmonary tuberculosis (TB) is a significant global health challenge.
  • Immune system dysregulation plays a critical role in TB pathogenesis.
  • Understanding the interplay between immune cells and TB progression is crucial for developing effective treatments.

Purpose:

  • To investigate the activity of natural killer (NK) cells and the counts of T lymphocyte subsets in patients with pulmonary tuberculosis.
  • To correlate immune cell profiles with radiological disease severity and extent.

Summary:

  • This study compared NK cell activity and T lymphocyte subset counts (CD4+, CD8+, CD3+) in 42 pulmonary TB patients and 32 healthy controls.
  • Pulmonary TB patients exhibited significantly higher NK cell activity (62.78 ± 27.54) compared to controls (39.39 ± 12.01).
  • Patients showed lower counts of CD4+ T cells (35.5 ± 9.3) and CD3+ T cells (51.5 ± 9.4) versus controls (43.8 ± 9.0 and 65.6 ± 11.1, respectively), with no significant change in the CD4+/CD8+ T cell ratio. NK cell activity positively correlated with TB lesion progression on X-ray, while T lymphocyte subset counts did not correlate with radiological severity.

Impact:

  • Findings suggest a potential role for NK cells in the immune response to pulmonary tuberculosis.
  • The data indicate that while T cell counts are altered, their ratio may not be a reliable marker for TB severity in this context.
  • Further research into NK cell function could reveal therapeutic targets for managing tuberculosis.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...